LaFee
Lv7
3970 积分
2022-06-27 加入
-
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
6个月前
已完结
-
老年胃癌患者手术并发症和非手术相关并发症的治疗对策
8个月前
已完结
-
对胃癌术后并发症的再认识
8个月前
已完结
-
[Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study]
9个月前
已完结
-
Safety and Efficacy of Neoadjuvant Chemotherapy for Advanced Gastric Cancer in Elderly Patients
10个月前
已完结
-
PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial
10个月前
已完结
-
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study
11个月前
已完结
-
Immunotherapy of MSI Cancer: Facts and Hopes
1年前
已完结
-
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
1年前
已完结
-
[China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing)]
1年前
已完结